Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 104051-104100 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04170153
Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)
PHASE1Active, not recruiting
161 participants
Started: Dec 20, 2019 · Completed: Jan 30, 2026
1 condition2 sponsors16 locations
NCT03969329
A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
PHASE3Recruiting
24 participants
Started: Dec 20, 2019 · Completed: Jun 30, 2027
1 condition1 sponsor23 locations
NCT04197934
WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases
PHASE1Recruiting
55 participants
Started: Dec 20, 2019 · Completed: Dec 20, 2025
5 conditions2 sponsors3 locations
NCT04052022
Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
N/ARecruiting
70 participants
Started: Dec 20, 2019 · Completed: Apr 30, 2029
1 condition1 sponsor1 location
NCT04237675
Postoperative Relapses in MS Patients
N/ARecruiting
300 participants
Started: Dec 20, 2019 · Completed: Dec 31, 2027
3 conditions1 sponsor2 locations
NCT04239625
Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)
PHASE2Active, not recruiting
200 participants
Started: Dec 20, 2019 · Completed: Dec 31, 2026
4 conditions1 sponsor8 locations
NCT06072079
Structural Chromosome Rearrangements and Brain Disorders
N/AEnrolling by invitation
10,000 participants
Started: Dec 20, 2019 · Completed: Dec 31, 2029
3 conditions2 sponsors1 location
NCT04012138
Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia
PHASE4Recruiting
525 participants
Started: Dec 20, 2019 · Completed: Jun 20, 2026
1 condition1 sponsor16 locations
NCT04080804
Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer
PHASE2Recruiting
80 participants
Started: Dec 20, 2019 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT04048421
Feasibility and Safety of Hybrid Transvaginal Natural Orifice Transluminal Endoscopic Surgery for Colon Cancer
NARecruiting
55 participants
Started: Dec 20, 2019 · Completed: Nov 30, 2025
2 conditions1 sponsor6 locations
NCT04194372
Signature of the Risk Profile of Mortality in a Hospital Cohort of Patients With Metabolic Diseases
N/ARecruiting
10,000 participants
Started: Dec 20, 2019 · Completed: Jan 31, 2030
1 condition1 sponsor3 locations
NCT05500859
Swiss Secondary Prevention and Rehabilitation Registry
N/ARecruiting
4,000 participants
Started: Dec 20, 2019 · Completed: Dec 31, 2035
1 condition1 sponsor1 location
NCT04335669
NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC
PHASE3Active, not recruiting
325 participants
Started: Dec 20, 2019 · Completed: Sep 30, 2035
2 conditions3 sponsors24 locations
NCT04175613
A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
PHASE3Active, not recruiting
160 participants
Started: Dec 20, 2019 · Completed: Dec 16, 2025
1 condition1 sponsor50 locations
NCT03904186
Effectiveness of an Integrated Treatment to Address Smoking Cessation and Anxiety/ Depression in People Living With HIV
NAActive, not recruiting
360 participants
Started: Dec 19, 2019 · Completed: Feb 28, 2025
7 conditions6 sponsors3 locations
NCT04163198
Optimisation of Mechanical Insufflation:Exsufflation
NARecruiting
30 participants
Started: Dec 19, 2019 · Completed: May 31, 2025
1 condition2 sponsors1 location
NCT03680508
TSR-022 (anti-TIM-3 Antibody) and TSR-042 (anti-PD-1 Antibody) in Patients with Liver Cancer
PHASE2Active, not recruiting
42 participants
Started: Dec 19, 2019 · Completed: Oct 31, 2027
3 conditions2 sponsors2 locations
NCT04485871
Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids
NARecruiting
48 participants
Started: Dec 19, 2019 · Completed: Oct 31, 2025
4 conditions2 sponsors1 location
NCT04191135
Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009)
PHASE2Active, not recruiting
462 participants
Started: Dec 19, 2019 · Completed: Nov 18, 2025
1 condition1 sponsor122 locations
NCT04236726
Investigating Health Related Quality of Life in Patients With Chronic Respiratory Failure
N/ARecruiting
200 participants
Started: Dec 19, 2019 · Completed: May 31, 2025
4 conditions1 sponsor1 location
NCT04164199
Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies
PHASE3Enrolling by invitation
430 participants
Started: Dec 19, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor107 locations
NCT04135846
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
PHASE2Recruiting
184 participants
Started: Dec 19, 2019 · Completed: Dec 20, 2025
1 condition1 sponsor1 location
NCT03993171
31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Multiple Sclerosis.
PHASE2Active, not recruiting
30 participants
Started: Dec 19, 2019 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT03948893
Smoking Cessation Behavioral Treatment Study
NARecruiting
200 participants
Started: Dec 19, 2019 · Completed: Mar 31, 2025
1 condition2 sponsors2 locations
NCT04286386
Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam
N/AActive, not recruiting
130 participants
Started: Dec 19, 2019 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT04328298
French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)
N/ARecruiting
5,000 participants
Started: Dec 19, 2019 · Completed: Dec 19, 2038
1 condition4 sponsors36 locations
NCT07025460
Darbepoetin Alfa Once Monthly Dosing Schedule Maintains Hemoglobin Concentration Comparable to Every 2 Weeks Dosing Schedule in Advanced Chronic Kidney Disease Patients Not on Dialysis: A Multicenter, Phase 4 Study
PHASE4Active, not recruiting
40 participants
Started: Dec 19, 2019 · Completed: Jan 18, 2026
1 condition1 sponsor1 location
NCT03998657
Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions
NAActive, not recruiting
14 participants
Started: Dec 19, 2019 · Completed: Dec 30, 2026
1 condition1 sponsor5 locations
NCT04165798
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
N/ARecruiting
1,065 participants
Started: Dec 19, 2019 · Completed: Feb 13, 2032
1 condition2 sponsors40 locations
NCT04165070
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
PHASE1/PHASE2Recruiting
450 participants
Started: Dec 19, 2019 · Completed: Feb 13, 2032
1 condition2 sponsors39 locations
NCT03986021
Reproductive Axis Maturation in the Early Post-Menarchal Years
N/ARecruiting
400 participants
Started: Dec 19, 2019 · Completed: Jul 1, 2029
4 conditions1 sponsor1 location
NCT04144231
Cognitive Behavioral Therapy for Insomnia (CBT-I) in Schizophrenia(SLEEPINS)
NARecruiting
120 participants
Started: Dec 19, 2019 · Completed: Sep 6, 2024
3 conditions4 sponsors1 location
NCT04073563
Transforaminal Lumbar Interbody Fusion (TLIF)
NAActive, not recruiting
600 participants
Started: Dec 19, 2019 · Completed: Jul 31, 2028
1 condition1 sponsor46 locations
NCT05215132
Investigational MRI Clinical Software and Hardware
PHASE4Recruiting
2,000 participants
Started: Dec 19, 2019 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT04337515
A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant
NARecruiting
90 participants
Started: Dec 19, 2019 · Completed: Jan 1, 2035
2 conditions1 sponsor1 location
NCT04047628
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
PHASE3Recruiting
156 participants
Started: Dec 19, 2019 · Completed: Oct 31, 2029
3 conditions5 sponsors20 locations
NCT03728049
Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes
NARecruiting
944 participants
Started: Dec 18, 2019 · Completed: Dec 31, 2025
2 conditions3 sponsors9 locations
NCT04232683
Preoperative Tamsulosin to Prevent Postoperative Urinary Retention After Surgery For Pelvic Floor Disorders
EARLY_PHASE1Active, not recruiting
100 participants
Started: Dec 18, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03495427
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores
PHASE2/PHASE3Recruiting
60 participants
Started: Dec 18, 2019 · Completed: May 31, 2029
2 conditions2 sponsors1 location
NCT03935971
The Effects of Dupilumab on Allergic Contact Dermatitis
PHASE4Active, not recruiting
9 participants
Started: Dec 18, 2019 · Completed: Jul 31, 2025
1 condition2 sponsors1 location
NCT04252989
Atropine 0.01% Eyedrops for Evolutive Myopia Treatment in Children
N/ARecruiting
50 participants
Started: Dec 18, 2019 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT04091126
Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma
PHASE1Active, not recruiting
118 participants
Started: Dec 18, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor30 locations
NCT04208919
Delayed Infusion of DCreg in Living Donor Liver Transplantation
PHASE1/PHASE2Active, not recruiting
24 participants
Started: Dec 18, 2019 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT04206436
CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis
N/AActive, not recruiting
63 participants
Started: Dec 18, 2019 · Completed: Dec 31, 2027
3 conditions2 sponsors1 location
NCT04075149
Does Treatment of Androgen Excess Using Spironolactone Improve Ovulatory Rates in Girls With Androgen Excess?
EARLY_PHASE1Recruiting
24 participants
Started: Dec 18, 2019 · Completed: Sep 1, 2024
3 conditions2 sponsors1 location
NCT04188743
Decolonization of Gram-negative Multi-resistant Organisms (MDRO) with Donor Microbiota (FMT)
PHASE2/PHASE3Recruiting
150 participants
Started: Dec 18, 2019 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT04208347
Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer
PHASE2/PHASE3Active, not recruiting
580 participants
Started: Dec 18, 2019 · Completed: Aug 31, 2025
1 condition1 sponsor23 locations
NCT04133675
BTL Emsella Chair Versus Sham for the Treatment of Stress Urinary Incontinence
NARecruiting
110 participants
Started: Dec 18, 2019 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT03881579
Supportive Care for Cognitively Impaired Patients and Families
NAActive, not recruiting
200 participants
Started: Dec 18, 2019 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT05934760
Assessing the Impact of Age, and a Short-term High-intensity Interval Training (HIIT) on Skeletal Muscle Mass and Mitochondrial Activity
NAActive, not recruiting
32 participants
Started: Dec 17, 2019 · Completed: Mar 30, 2024
2 conditions1 sponsor1 location